Sydlik Carmen, Dubinski Ilja, Bechtold Susanne, Schmidt Heinrich
Division of Pediatric Endocrinology, Center for Pediatric and Adolescent Medicine Inn-Salzach-Rott, Altoetting, Germany.
Division of Pediatric Endocrinology, Dr. von Hauner Children's Hospital, University Hospital Munich, LMU Munich, Munich, Germany.
Endocr Connect. 2022 Jul 14;11(7). doi: 10.1530/EC-22-0032. Print 2022 Jul 1.
Thyroid-stimulating hormone is generally regarded as a standard parameter for the evaluation of thyroid function. However, relying on this hormone alone can be misleading. Therefore, thyroxine/free-thyroxine levels are used in patients with levothyroxine substitution for the adjustment of therapy. Even with normal values for free thyroxine, decreased values for the free-triiodothyronine/free-thyroxine ratio have already been described in adults. In this study, the free-triiodothyronine/free-thyroxine ratio of 25 children with congenital hypothyroidism was compared with 470 healthy children seen for other reasons and then for thyroid dysfunction. Mean free thyroxine in congenital hypothyroidism was just below the upper limit of normal and significantly higher than in control group. Mean values for free triiodothyronine showed no significant difference between the two groups. The mean value for the free triiodothyronine/free-thyroxine ratio in control group was 3.23. Significantly lower ratios were found in the congenital hypothyroidism group with a mean value of 2.5, due to higher values for free thyroxine compared to free triiodothyronine. Furthermore, an increased free triiodothyronine/free-thyroxine ratio was found at higher thyroid-stimulating hormone values due to lower values for free thyroxine. In this study, we demonstrate that the free triiodothyronine/free-thyroxine ratio was significantly lower in children with congenital hypothyroidism compared to the control group. This is most likely due to the higher values for free thyroxine in this group compared to similar values for free triiodothyronine in both groups. Further studies with differentiated thyroid hormone therapy are needed in order to understand the role of peripheral euthyroidism.
促甲状腺激素通常被视为评估甲状腺功能的标准参数。然而,仅依靠这种激素可能会产生误导。因此,左甲状腺素替代治疗的患者会使用甲状腺素/游离甲状腺素水平来调整治疗方案。即使游离甲状腺素值正常,成人中也已发现游离三碘甲状腺原氨酸/游离甲状腺素比值降低。在本研究中,将25例先天性甲状腺功能减退患儿的游离三碘甲状腺原氨酸/游离甲状腺素比值与470例因其他原因就诊且随后被诊断为甲状腺功能障碍的健康儿童进行了比较。先天性甲状腺功能减退患儿的平均游离甲状腺素略低于正常上限,且显著高于对照组。两组的游离三碘甲状腺原氨酸平均值无显著差异。对照组的游离三碘甲状腺原氨酸/游离甲状腺素比值平均值为3.23。先天性甲状腺功能减退组的比值显著更低,平均值为2.5,这是因为与游离三碘甲状腺原氨酸相比,游离甲状腺素值更高。此外,由于游离甲状腺素值较低,在促甲状腺激素值较高时发现游离三碘甲状腺原氨酸/游离甲状腺素比值升高。在本研究中,我们证明先天性甲状腺功能减退患儿的游离三碘甲状腺原氨酸/游离甲状腺素比值显著低于对照组。这很可能是由于该组游离甲状腺素值高于两组中游离三碘甲状腺原氨酸的相似值。为了了解外周甲状腺功能正常的作用,需要进一步开展关于差异化甲状腺激素治疗的研究。